Naya Biosciences, Stock Revenue
| NAYA Stock | 0.35 0.01 2.78% |
NAYA Biosciences, fundamentals help investors to digest information that contributes to NAYA Biosciences,'s financial success or failures. It also enables traders to predict the movement of NAYA Stock. The fundamental analysis module provides a way to measure NAYA Biosciences,'s intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to NAYA Biosciences, stock.
| Last Reported | Projected for Next Year | ||
| Total Revenue | 3.5 M | 2.5 M |
NAYA | Revenue |
NAYA Biosciences, Company Revenue Analysis
NAYA Biosciences,'s Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Current NAYA Biosciences, Revenue | 3.02 M |
Most of NAYA Biosciences,'s fundamental indicators, such as Revenue, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, NAYA Biosciences, is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Historical and Projected quarterly revenue of NAYA
Projected quarterly revenue analysis of NAYA Biosciences, provides investors and stakeholders with an insight into the company's performance and growth prospects. When actual revenues of NAYA Biosciences, match or exceed analyst estimates, it positively influences investor confidence and market perception, often leading to a rise in NAYA Biosciences,'s stock price.
NAYA Revenue Driver Correlations
Understanding the fundamental principles of building solid financial models for NAYA Biosciences, is extremely important. It helps to project a fair market value of NAYA Stock properly, considering its historical fundamentals such as Revenue. Since NAYA Biosciences,'s main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of NAYA Biosciences,'s historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of NAYA Biosciences,'s interrelated accounts and indicators.
| -0.73 | -0.57 | 0.06 | -0.53 | -0.53 | ||
| -0.73 | 0.62 | 0.02 | 0.66 | 0.52 | ||
| -0.57 | 0.62 | 0.02 | 0.2 | 0.49 | ||
| 0.06 | 0.02 | 0.02 | -0.08 | -0.17 | ||
| -0.53 | 0.66 | 0.2 | -0.08 | 0.76 | ||
| -0.53 | 0.52 | 0.49 | -0.17 | 0.76 |
Click cells to compare fundamentals
NAYA Revenue Historical Pattern
Today, most investors in NAYA Biosciences, Stock are looking for potential investment opportunities by analyzing not only static indicators but also various NAYA Biosciences,'s growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's revenue growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of NAYA Biosciences, revenue as a starting point in their analysis.
NAYA Biosciences, Revenue |
| Timeline |
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
| Competition |
NAYA Current Deferred Revenue
Current Deferred Revenue |
|
Based on the latest financial disclosure, NAYA Biosciences, reported 3.02 M of revenue. This is 99.96% lower than that of the Healthcare sector and 99.88% lower than that of the Medical Devices industry. The revenue for all United States stocks is 99.97% higher than that of the company.
NAYA Revenue Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses NAYA Biosciences,'s direct or indirect competition against its Revenue to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of NAYA Biosciences, could also be used in its relative valuation, which is a method of valuing NAYA Biosciences, by comparing valuation metrics of similar companies.NAYA Biosciences, is currently under evaluation in revenue category among its peers.
NAYA Biosciences, Current Valuation Drivers
We derive many important indicators used in calculating different scores of NAYA Biosciences, from analyzing NAYA Biosciences,'s financial statements. These drivers represent accounts that assess NAYA Biosciences,'s ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of NAYA Biosciences,'s important valuation drivers and their relationship over time.
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Market Cap | 760.9K | 1.5M | 1.7M | 2.2M | 2.0M | 2.1M | |
| Enterprise Value | (8.6M) | (2.1M) | 3.9M | 8.2M | 7.4M | 7.8M |
NAYA Fundamentals
| Current Valuation | 14.07 M | ||||
| Shares Outstanding | 4.48 M | ||||
| Shares Owned By Insiders | 15.56 % | ||||
| Shares Owned By Institutions | 2.88 % | ||||
| Number Of Shares Shorted | 244.26 K | ||||
| Price To Book | 5.97 X | ||||
| Price To Sales | 0.18 X | ||||
| Revenue | 3.02 M | ||||
| EBITDA | (6.88 M) | ||||
| Net Income | (8.03 M) | ||||
| Total Debt | 6.3 M | ||||
| Book Value Per Share | (3.91) X | ||||
| Cash Flow From Operations | (4.76 M) | ||||
| Short Ratio | 0.78 X | ||||
| Earnings Per Share | (1.01) X | ||||
| Target Price | 2.0 | ||||
| Market Capitalization | 2.48 M | ||||
| Total Asset | 18.51 M | ||||
| Retained Earnings | (57.82 M) | ||||
| Working Capital | (6.74 M) | ||||
| Net Asset | 18.51 M |
About NAYA Biosciences, Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze NAYA Biosciences,'s financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of NAYA Biosciences, using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of NAYA Biosciences, based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether NAYA Biosciences, offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of NAYA Biosciences,'s financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Naya Biosciences, Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Naya Biosciences, Stock:Check out NAYA Biosciences, Piotroski F Score and NAYA Biosciences, Altman Z Score analysis. For information on how to trade NAYA Stock refer to our How to Trade NAYA Stock guide.You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Is Medical Equipment space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of NAYA Biosciences,. If investors know NAYA will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about NAYA Biosciences, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.01) |
The market value of NAYA Biosciences, is measured differently than its book value, which is the value of NAYA that is recorded on the company's balance sheet. Investors also form their own opinion of NAYA Biosciences,'s value that differs from its market value or its book value, called intrinsic value, which is NAYA Biosciences,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because NAYA Biosciences,'s market value can be influenced by many factors that don't directly affect NAYA Biosciences,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between NAYA Biosciences,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if NAYA Biosciences, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, NAYA Biosciences,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.